Reference
Health Canada. Evotaz (atazanavir and cobicistat) and Reyataz (atazanavir). Health Product InfoWatch : 7, Jul 2017. Available from: URL: https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/medeffect-canada/health-product-infowatch/health-product-infowatch-july-2017/hpiw-ivps_2017-07-eng.pdf
Rights and permissions
About this article
Cite this article
Risk of kidney disease with atazanavir-containing products. Reactions Weekly 1664, 3 (2017). https://doi.org/10.1007/s40278-017-34283-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-34283-1